Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul:87:155-158.
doi: 10.1016/j.bbi.2020.05.022. Epub 2020 May 7.

Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Affiliations
Case Reports

Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Lerzan Dogan et al. Brain Behav Immun. 2020 Jul.

Abstract

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Keywords: Autoimmune; COVID-19; Encephalitis; Plasmapheresis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Case 1: A through C. A: Axial FLAIR showing bilateral segmental frontal cortical hyperintensity together with focal effacement of right frontal sulci. T1WI images showed mild pial-subarachnoid enhancement after I.V. Gad and DWI showed frontal cortical hyperintensity without matching hypointensity on ADC mapping (data not provided). All findings were considered compatible with meningoencephalitis. Following plasmapheresis, there was prominent regression of FLAIR findings at the first (B) and second (C) week’s follow-up imaging. Similarly, DWI hyperintensities disappeared and contrast enhancement regressed following treatment (data not provided). Case 2: D through F. D: Axial FLAIR showing bilateral extensive hyperintense signal changes of the frontal and parietal white matter accompanied by focal frontal cortical hyperintensity. As in Case 1, DWI images showed matching areas of diffusion restrictions (data not provided); the findings were considered compatible with meningoencephalitis. Following plasmapheresis, there was a prominent regression on FLAIR at the first (E) and second (F) week’s follow-up imaging. These also showed linear pial-subarachnoid hyperintensity within the right frontal sulci on the second week’s follow-up FLAIR compatible with subarachnoid hemorrhage (F).
Fig. 2
Fig. 2
Ferritin levels before and after plasmapheresis. (Pf: plasmapheresis).

References

    1. Ritchie Andrew I, Singanayagam Aran. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? The Lancet. 2020;395(10230):1111. doi: 10.1016/S0140-6736(20)30691-7. - DOI - PMC - PubMed
    1. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11(7):995–998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13. - DOI - PubMed
    1. Duong L., Xu P., Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 Infection in Downtown Los Angeles, Early April 2020. Brain, Behavior. Immun. 2020 doi: 10.1016/j.bbi.2020.04.024. - DOI - PMC - PubMed
    1. Faure E., Poissy J., Goffard A. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One. 2014;9 - PMC - PubMed
    1. He L., Ding Y., Zhang Q., Che X., He Y., Shen H., Wang H. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 2006;210:288–297. - PMC - PubMed

Publication types